Lupin receives ENR Global Best Project Award for Nagpur facility

Pharma/BioPharma |  News | 0 Comment | 22 Jul, 2019

Pharma major Lupin Limited (Lupin) announced that it has won the Engineering News-Record’s (ENR) Global Best Project Award of Merit in the Manufacturing category. The award was given ...Read more

Cipla gets final approval for generic version of Pfizer’s Lyrica

Pharma/BioPharma |  News | 0 Comment | 22 Jul, 2019

InvaGen Pharmaceuticals, Inc. (“InvaGen”), a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited announced the receipt of final approval for its A...Read more

Bayer, Bristol-Myers Squibb and Ono Pharma enter into clinical collaboration

Pharma/BioPharma |  News | 0 Comment | 19 Jul, 2019

Bayer, Bristol-Myers Squibb Company and Ono Pharmaceutical Co., Ltd. have entered into a clinical collaboration agreement to evaluate the combination of Bayer's kinase inhibitor Stivarga&re...Read more

Zydus completes enrollment in 3 Phase III trials of NASH drug

Pharma/BioPharma |  News | 0 Comment | 19 Jul, 2019

Zydus Cadila, an innovation-driven, global pharmaceutical company, announced that it has completed enrollment in EVIDENCES II, EVIDENCES III and EVIDENCES V Phase 3 clinical trials of Sarog...Read more

FDA approves Bayer's Gadavist® injection for use in cardiac MR

Pharma/BioPharma |  News | 0 Comment | 16 Jul, 2019

Bayer announced the U.S. Food and Drug Administration (FDA) has approved Gadavist® (gadobutrol) injection for use in cardiac magnetic resonance (MR) imaging to assess myocardial pe...Read more

Cipla EU, Jiangsu Acebright enter into a joint venture

Pharma/BioPharma |  News | 0 Comment | 16 Jul, 2019

Cipla (EU) Limited, a U.K. based wholly-owned subsidiary of the leading global pharmaceutical company Cipla and Jiangsu Acebright Pharmaceutical Co. Ltd.have announced that t...Read more

Experts focus on critical management of pharma supply chain

Pharma/BioPharma |  News | 0 Comment | 12 Jul, 2019

In the emerging age of biologics, gene therapies and personalised medicine, pharmaceutical products – drugs and medicines – will have short lifespans, must be shipped in tightly...Read more

Lupin launches Imatinib Mesylate tablets

Pharma/BioPharma |  News | 0 Comment | 10 Jul, 2019

Pharma major Lupin Limited (Lupin) announced the launch of Imatinib Mesylate Tablets, 100 mg (base) and 400 mg (base). Lupin’s alliance partner Natco had received an approval from the...Read more

Dr. Reddy’s launches OTC store brand equivalent of Mucinex® D tablets

Pharma/BioPharma |  News | 0 Comment | 09 Jul, 2019

Dr. Reddy’s Laboratories Ltd. has announced the launch of an over-the-counter (OTC) store-brand equivalent of Mucinex® D Extended Release Tablets in two strengths—Guaifenesi...Read more

Glenmark receives ANDA approval for Ranolazine Extended-Release Tablets

Pharma/BioPharma |  News | 0 Comment | 09 Jul, 2019

Glenmark Pharmaceuticals Inc. has been granted final approval by the United States Food & Drug Administration for Ranolazine Extended-Release Tablets, 500 mg and 1,000 mg, a generic ver...Read more

IIL organises animal vaccination camps

Pharma/BioPharma |  News | 0 Comment | 09 Jul, 2019

Indian Immunologicals Limited (IIL), a leading biologicals company, recently organized free Vaccination Camps in over 170 centres across the country. The market leader in veterinary biologi...Read more

GSK gets EU marketing nod for its HIV drug

Pharma/BioPharma |  News | 0 Comment | 04 Jul, 2019

ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, have announced that the European Commission has...Read more

Dr. Reddy's announces first-to-market launch of Carboprost Tromethamine Injection USP

Pharma/BioPharma |  News | 0 Comment | 03 Jul, 2019

Dr. Reddy’s Laboratories Ltd., along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Carboprost Tromethamine Injection USP...Read more

Alembic Pharmaceuticals receives USFDA approval for Febuxostat tablets

Pharma/BioPharma |  News | 0 Comment | 02 Jul, 2019

Alembic Pharmaceuticals Limited has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Febuxostat Tablets, 40 mg and 80 mg....Read more

Alembic Pharma set to treat seizures with Clonazepam

Pharma/BioPharma |  News | 0 Comment | 02 Jul, 2019

Alembic Pharmaceuticals Limited has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Clonazepam Orally Disintegrating Tab...Read more

Glenmark receives ANDA approval for Ezetimibe and Simvastatin Tablets

Pharma/BioPharma |  News | 0 Comment | 28 Jun, 2019

Glenmark Pharmaceuticals has been granted final approval by the USFDA for Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg, a generic version of Vyt...Read more

Sun Pharma enters into two agreements with China Medical System

Pharma/BioPharma |  News | 0 Comment | 28 Jun, 2019

Sun Pharmaceutical has announced that one of its wholly owned subsidiaries has entered into two exclusive licensing agreement with a subsidiary of China Medical System Holdings Ltd. (CMS) f...Read more

Hilleman Lab licenses Oral Cholera Vaccine Hillchol to Bharat Biotech

Pharma/BioPharma |  News | 0 Comment | 26 Jun, 2019

Hilleman Laboratories, a global research and development organization focused on delivering high-impact and affordable vaccines, has announced that it has entered into a collabora...Read more